AIM • STX • GB00BYV81293
Generating your data highlights...
N/A USD | # 3477 in GB
2.97m shares | 200.27k USD
1.07b
38.64% | 413.4m
Shield Therapeutics (AIM: STX). Last close 5.55 GBp; 52-week range 3.7 GBp to 12.5 GBp. ORTEX data as of 2026-10-19: short interest is 0.39% of free float, 0.9 days to cover and the average cost to borrow is 8.89%.